CGON
Financials
- Market Capitalization 6.37 B
- Employee 142
- Founded 2010
- CEO N/A
- Website www.cgoncology.com
- Headquarter Delaware, United States
- FIGI BBG00YHKK4Q3
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 418 |  ONC BeOne Medicines Ltd - American Depositary Shares | 311.89 USD | +1.74% | +2.85% | +16.25% | -1.21% | 34.67 B USD | ||
| 474 |  BIIB Biogen Inc. - Common Stock | 190.97 USD | -0.51% | -6.17% | -4.37% | +48.63% | 28.19 B USD | ||
| 1302 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 85.93 USD | -1.76% | -0.99% | +24.45% | +167.95% | 5.18 B USD | ||
| 1396 |  MANE Veradermics, Incorporated Common Stock | 125.49 USD | +14.20% | +4.36% | +31.18% | +280.27% | 5.24 B USD |
Frequently asked questions about CG Oncology, Inc. - Common stock
What is the CG Oncology, Inc. - Common stock stock price today?
The current price of CG Oncology, Inc. - Common stock (CGON) is 72.18. Over the past 24 hours, the stock has changed by +0.57%. Follow the CGON chart for real-time price dynamics.
What is the stock ticker of CG Oncology, Inc. - Common stock?
CG Oncology, Inc. - Common stock trades under the ticker CGON. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CG Oncology, Inc. - Common stock stock going up?
CGON has changed by +4.96% over the last week, +19.42% over the last month, and +65.70% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was CG Oncology, Inc. - Common stock net income for the last quarter?
CG Oncology, Inc. - Common stock reported net income of -60.2 M for the last quarter. The previous quarter showed -41.31 M, which means net income changed by -45.74%.
How many employees does CG Oncology, Inc. - Common stock have?
As of the latest available data, CG Oncology, Inc. - Common stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.
What is CG Oncology, Inc. - Common stock EBITDA?
CG Oncology, Inc. - Common stock EBITDA is -86.33 M, and its EBITDA margin is -7 971.19%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CG Oncology, Inc. - Common stock stock?
You can buy CG Oncology, Inc. - Common stock (CGON) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CG Oncology, Inc. - Common stock stock?
Investing in CG Oncology, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CGON chart and related analysis on metatrader.com as part of your research.